Menu Back toV2-S3

14th DIA Japan Annual Meeting 2017

[V2-S3] Artificial Intelligence Leads to Realize Medical Innovation

    Session Chair(s)
      Hiroyuki  Mano, MD, PhD

      Hiroyuki Mano, MD, PhD

      • Director, National Cancer Center Research Institute / Professor,
      • Dept of Cellular Signaling, Graduate School of Medicine, The University of Tokyo, Japan
    The advancement of digital tools and technologies such as artificial intelligence (AI), which aims at creating new industries and improvements of efficiency in research and development, raises more expectations on medical innovation including three major components (Government, Academia and Industry), quality and safety of medical care, advanced medical care and more efficient medical service, This session will provide an overview of the future of digital health by introducing an example of better use AI; Watson for Genomics for gene therapy and Watson for Drug Discovery for transforming drug discovery and health. At the panel discussion, the current situation and challenges surrounding advancing AI technologies and ideal medical use will be discussed. In addition, the session will provide real AI use with Watson as a hands on experience.
      Toshifumi  Wakai, MD, PhD

      Precision Medicine Based on Genome Analysis: Actual and Future Prospect for Medical Artificial Intelligence Development

      Toshifumi Wakai, MD, PhD

      • Professor and Chairman, Division of Digestive and General Surgery
      • Niigata University Graduate School of Medical and Dental Sciences, Japan
      Toshifumi  Mizokami

      IBM Watson Health – Transforming Drug Discovery & Health

      Toshifumi Mizokami

      • Manager, Watson Health Solutions
      • IBM Japan,Ltd., Japan

Contact us

Please contact the DIA Japan office in Tokyo for further information.

Tel: +81-3-6214-0574
Fax: +81-3-3278-1313